SCHEMBL712586

SCHEMBL712586

CC1(C)OCC(O)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17818431 0.77 TSHR (0.36)
SCHEMBL20746431 0.73
SCHEMBL14321383 0.73 MEN1 (0.33)
SCHEMBL4791245 0.73
SCHEMBL265168 0.71
SCHEMBL4656389 0.71
SCHEMBL4235492 0.71
SCHEMBL9807213 0.71
SCHEMBL1947771 0.71
SCHEMBL9807214 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242500-A1 METHOD FOR MANUFACTURING (2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)METHANOL ECOLE NATIONALE SUPERIEURE DE CHIMIE DE PARIS (FR) 2023-08-03 US claimed
US-8563179-B2 Nonaqueous secondary battery SANYO ELECTRIC CO., LTD. (JP) 2013-10-22 US claimed
EP-4714952-A1 COMPOUND AND USE THEREOF Autobio Group Co., Ltd. (CN) 2026-03-25 EP disclosed
EP-4702044-A1 GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS WITH BIO-DISTRIBUTION MODIFIER 3B Pharmaceuticals GmbH (DE) 2026-03-04 EP disclosed
EP-4619378-A2 IONIZABLE LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF NUCLEIC ACIDS Seawolf Therapeutics, Inc. (US) 2025-09-24 EP disclosed
US-20250235404-A1 PEG-LIPIDS AND LIPID NANOPARTICLES CAPSTAN THERAPEUTICS, INC. 2025-07-24 US disclosed
CN-120202184-A Ionizable lipids and lipid nanoparticle compositions for delivery of nucleic acids 海狼治疗公司 2025-06-24 CN disclosed
WO-2025119893-A1 SUBSTITUTED BICYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2025-06-12 WO disclosed
EP-3668878-B1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN AMGEN INC (US) 2025-05-21 EP disclosed
CN-113166065-B Compounds and compositions for treating disorders associated with NLRP activity 诺华股份有限公司 2025-04-15 CN disclosed
EP-4504265-A1 PEG-LIPIDS AND LIPID NANOPARTICLES Capstan Therapeutics, Inc. (US) 2025-02-12 EP disclosed
US-6018001-A ACID TREATMENT OF A CONTACT LENS WHICH IS A COPOLYMER OF ASUGAR KETAL-CONTAINING (METH)ACRYLATE AND A SUGAR GLYCEROL KETAL-CONTAINING (METH)ACRYLATE AND A CO-MONOMER CONTAINING SILICON AND FLUORINE-MONOMER; OXYGEN PERMEABILITY MENICON CO., LTD. (JP) 2000-01-25 US disclosed
EP-0456073-B1 Multifunctional compounds having alpha-diazo-beta-ketoester units and sulfonic acid ester units and process for their preparation. HOECHST AG (DE) 1995-10-25 EP disclosed
US-5451654-A Addition polymerization catalyst ELF ATOCHEM NORTH AMERICA, INC. (US) 1995-09-19 US disclosed
US-5387654-A Hydroxy-peroxides and their uses ELF ATOCHEM NORTH AMERICA, INC. (US) 1995-02-07 US disclosed
EP-0381135-B1 Novel hydroxy-peroxides and their uses ATOCHEM NORTH AMERICA (US) 1994-06-01 EP disclosed
US-5304649-A Curing agent for unsaturated polyesters ELF ATOCHEM NORTH AMERICA, INC. (US) 1994-04-19 US disclosed
US-5191069-A Photosensitive compounds with heat resistance HOECHST AKTIENGESELLSCHAFT (DE) 1993-03-02 US disclosed
EP-0456073-A2 Multifunctional compounds having alpha-diazo-beta-ketoester units and sulfonic acid ester units and process for their preparation. HOECHST AKTIENGESELLSCHAFT (DE) 1991-11-13 EP disclosed
EP-0381135-A2 Novel hydroxy-peroxides and their uses ATOCHEM NORTH AMERICA, INC. (US) 1990-08-08 EP disclosed